Avicin D: A Protein Reactive Plant Isoprenoid Dephosphorylates Stat 3 by Regulating Both Kinase and Phosphatase Activities
暂无分享,去创建一个
J. Gutterman | Zhi-xiang Xu | V. Haridas | Z. Walaszek | M. Hanausek | Goshi Nishimura | F. Connolly | Robert Żółtaszek
[1] B. Eipper,et al. :Posttranslational Modification of Proteins: Expanding Nature's Inventory , 2008 .
[2] J. Gutterman,et al. Avicin D selectively induces apoptosis and downregulates p-STAT-3, bcl-2, and survivin in cutaneous T-cell lymphoma cells. , 2008, The Journal of investigative dermatology.
[3] J. Cáceres-Cortés. A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490. , 2008, Anti-cancer agents in medicinal chemistry.
[4] J. Gutterman,et al. A plant triterpenoid, avicin D, induces autophagy by activation of AMP-activated protein kinase , 2007, Cell Death and Differentiation.
[5] Hua Yu,et al. Cutting Edge: An In Vivo Requirement for STAT3 Signaling in TH17 Development and TH17-Dependent Autoimmunity1 , 2007, The Journal of Immunology.
[6] G. Stark,et al. Unphosphorylated STAT3 accumulates in response to IL-6 and activates transcription by binding to NFkappaB. , 2007, Genes & development.
[7] J. Gutterman,et al. Avicins, a novel plant-derived metabolite lowers energy metabolism in tumor cells by targeting the outer mitochondrial membrane. , 2007, Mitochondrion.
[8] J. Gutterman,et al. Avicins, natural anticancer saponins, permeabilize mitochondrial membranes. , 2006, Archives of biochemistry and biophysics.
[9] L. Klampfer,et al. Signal transducers and activators of transcription (STATs): Novel targets of chemopreventive and chemotherapeutic drugs. , 2006, Current cancer drug targets.
[10] Sylvie Garneau-Tsodikova,et al. Protein posttranslational modifications: the chemistry of proteome diversifications. , 2005, Angewandte Chemie.
[11] Ian Paterson,et al. The Renaissance of Natural Products as Drug Candidates , 2005, Science.
[12] Christopher T. Walsh,et al. Posttranslational Modification of Proteins: Expanding Nature's Inventory , 2005 .
[13] B. Cravatt,et al. Protein-reactive natural products. , 2005, Angewandte Chemie.
[14] G. Semenza,et al. Targeting Stat3 blocks both HIF-1 and VEGF expression induced by multiple oncogenic growth signaling pathways , 2005, Oncogene.
[15] C. Walsh. Natural insights for chemical biologists , 2005, Nature chemical biology.
[16] A. Hausladen,et al. Avicinylation (thioesterification): a protein modification that can regulate the response to oxidative and nitrosative stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[17] R. Jove,et al. Stat3 regulates genes common to both wound healing and cancer , 2005, Oncogene.
[18] S. Shenolikar,et al. Importance of a Surface Hydrophobic Pocket on Protein Phosphatase-1 Catalytic Subunit in Recognizing Cellular Regulators* , 2005, Journal of Biological Chemistry.
[19] N. Blackstone,et al. Mitochondria as integrators of information in an early-evolving animal: insights from a triterpenoid metabolite , 2005, Proceedings of the Royal Society B: Biological Sciences.
[20] J. Gutterman,et al. Triterpenoid Electrophiles (Avicins) Suppress Heat Shock Protein-70 and X-Linked Inhibitor of Apoptosis Proteins in Malignant Cells by Activation of Ubiquitin Machinery: Implications for Proapoptotic Activity , 2005, Clinical Cancer Research.
[21] F. Koehn,et al. The evolving role of natural products in drug discovery , 2005, Nature Reviews Drug Discovery.
[22] Xianyue Ma,et al. Identification of 1,2,3,4,5,6-hexabromocyclohexane as a small molecule inhibitor of Jak2 tyrosine kinase autophophorylation , 2005 .
[23] N. Munshi,et al. Avicins: A Novel Class of Anti-Myeloma Agents. , 2004 .
[24] C. Clevenger. Roles and regulation of stat family transcription factors in human breast cancer. , 2004, The American journal of pathology.
[25] David A. Frank,et al. Genome-wide analysis of STAT target genes: Elucidating the mechanism of STAT-mediated oncogenesis , 2004, Cancer biology & therapy.
[26] K. Kiguchi,et al. Disruption of Stat3 reveals a critical role in both the initiation and the promotion stages of epithelial carcinogenesis. , 2004, The Journal of clinical investigation.
[27] J. Folkman. Endogenous angiogenesis inhibitors , 2004, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[28] E. Ulukaya,et al. Interference by Anti-Cancer Chemotherapeutic Agents in the MTT-Tumor Chemosensitivity Assay , 2004, Chemotherapy.
[29] Ash A. Alizadeh,et al. Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds , 2004, PLoS biology.
[30] Nicola Gebbia,et al. STAT proteins: From normal control of cellular events to tumorigenesis , 2003, Journal of cellular physiology.
[31] B. Aggarwal,et al. Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells 1 , 2003, The Journal of Immunology.
[32] G. Semenza. Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.
[33] M. Masuda,et al. Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[34] D. T. Bailey,et al. Isolation and structures of avicins D and G: in vitro tumor-inhibitory saponins derived from Acacia victoriae. , 2003, Journal of natural products.
[35] F. Rohwer,et al. IL-2 activation of a PI3K-dependent STAT3 serine phosphorylation pathway in primary human T cells. , 2003, Cellular signalling.
[36] A. Svejgaard,et al. Constitutive STAT3 Activation in Intestinal T Cells from Patients with Crohn's Disease* , 2003, The Journal of Biological Chemistry.
[37] Heinz Baumann,et al. Signal transducer and activator of transcription proteins in leukemias. , 2003, Blood.
[38] R. DePinho,et al. The age of cancer: telomeres, checkpoints, and longevity. , 2003, The Journal of clinical investigation.
[39] S. Bhattacharya,et al. Regulation of Stat3 nuclear export. , 2003, The Journal of clinical investigation.
[40] P. Padilla,et al. Dephosphorylation of cell cycle-regulated proteins correlates with anoxia-induced suspended animation in Caenorhabditis elegans. , 2002, Molecular biology of the cell.
[41] L. Ellis,et al. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis , 2002, Oncogene.
[42] Jack C. Schultz,et al. Biochemical ecology: How plants fight dirty , 2002, Nature.
[43] S. Bhattacharya,et al. Signaling through the JAK/STAT pathway, recent advances and future challenges. , 2002, Gene.
[44] T. Slaga,et al. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), suppress H-ras mutations and aneuploidy in a murine skin carcinogenesis model , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Gutterman,et al. Avicins, a family of triterpenoid saponins from Acacia victoriae (Bentham), inhibit activation of nuclear factor-κB by inhibiting both its nuclear localization and ability to bind DNA , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[46] G. Mills,et al. Triterpenoid saponins from Acacia victoriae (Bentham) decrease tumor cell proliferation and induce apoptosis. , 2001, Cancer research.
[47] J. Gutterman,et al. Avicins: Triterpenoid saponins from Acacia victoriae (Bentham) induce apoptosis by mitochondrial perturbation , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[48] J. Herman,et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity , 2001, Nature Genetics.
[49] J. Grandis,et al. STAT signaling in head and neck cancer , 2000, Oncogene.
[50] Roy Garcia,et al. STATs in oncogenesis , 2000, Oncogene.
[51] Xinmin Cao,et al. Serine Phosphorylation and Negative Regulation of Stat3 by JNK* , 1999, The Journal of Biological Chemistry.
[52] J. Darnell,et al. Stat3 as an Oncogene , 1999, Cell.
[53] C. Geisler,et al. Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[54] Tong Zhang,et al. Protein Kinase C δ Associates with and Phosphorylates Stat3 in an Interleukin-6-dependent Manner* , 1999, The Journal of Biological Chemistry.
[55] J. O'flaherty,et al. Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines. , 1999, The Biochemical journal.
[56] L. Ivashkiv,et al. Rapid inhibition of interleukin-6 signaling and Stat3 activation mediated by mitogen-activated protein kinases. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[57] J. Hagood,et al. STAT3 Acts as a Co-activator of Glucocorticoid Receptor Signaling* , 1997, The Journal of Biological Chemistry.
[58] D. Green,et al. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl , 1995, The Journal of experimental medicine.
[59] Georg Breier,et al. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo , 1992, Nature.
[60] M. Bollen,et al. Functional diversity of protein phosphatase-1, a cellular economizer and reset button. , 2004, Physiological reviews.
[61] J. Gutterman,et al. Triterpenoid electrophiles (avicins) activate the innate stress response by redox regulation of a gene battery. , 2004, The Journal of clinical investigation.
[62] J. Avruch,et al. Serine phosphorylation and maximal activation of STAT3 during CNTF signaling is mediated by the rapamycin target mTOR , 2000, Current Biology.
[63] J. Turkson,et al. Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.
[64] D. Frank,et al. STAT signaling in the pathogenesis and treatment of cancer. , 1999, Molecular medicine.
[65] W. Leonard,et al. Jaks and STATs: biological implications. , 1998, Annual review of immunology.
[66] J. Darnell,et al. Transcriptional responses to polypeptide ligands: the JAK-STAT pathway. , 1995, Annual review of biochemistry.